Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

Autor: Bhatt, Dl, Szarek, M, Pitt, B, Cannon, Cp, Leiter, La, Mcguire, Dk, Lewis, Jb, Riddle, Mc, Inzucchi, Se, Kosiborod, Mn, Cherney, Dzi, Dwyer, Jp, Scirica, Bm, Bailey, Cj, Díaz, R, Ray, Kk, Udell, Ja, Lopes, Rd, Lapuerta, P, Steg, Gabriel, P, Lauro, D

Publikováno v: Bhatt, D L, Szarek, M, Pitt, B, Cannon, C P, Leiter, L A, McGuire, D K, Lewis, J B, Riddle, M C, Inzucchi, S E, Kosiborod, M N, Cherney, D Z I, Dwyer, J P, Scirica, B M, Bailey, C J, Díaz, R, Ray, K K, Udell, J A, Lopes, R D, Lapuerta, P, Steg, P G & SCORED Investigators 2021, ' Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease ', The New England Journal of Medicine, vol. 384, no. 2, pp. 129-139 . https://doi.org/10.1056/NEJMoa2030186
NEW ENGLAND JOURNAL OF MEDICINE
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

In a trial involving 10,584 patients with diabetes and chronic kidney disease, sotagliflozin resulted in fewer total deaths from cardiovascular causes, hospitalizations for heart failure, and urgent visits for heart failure than placebo. Diarrhea, my

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e9705eeadc025b1e0478507d16cdaa4
https://pure.au.dk/portal/da/publications/sotagliflozin-in-patients-with-diabetes-and-chronic-kidney-disease(6bc50c6b-8a7a-4eea-bd9e-9032680e8b64).html

Everlasting Flower: A History of Korea

Autor: Lewis, JB

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c883a9394c6828732fa2f500139498f9
https://ora.ox.ac.uk/objects/uuid:9ecec7b4-6234-4083-a036-2bcc84ff6075

Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals The ARB Trialists Collaboration

Autor: Teo, KK, Sleight, P, Gao, P, Yusuf, S, Connolly, S, Swedberg, K, Pfeffer, MA, Granger, CB, McMurray, JJV, Sjoelie, AK, Massie, BM, Carson, P, Lewis, JB, Wachtell, K, Dahlof, B, Devereux, RB, Kjeldsen, SE, Julius, S, Ibsen, H, Lindholm, LH, Olsen, MH, Okin, PM, Califf, R, Holman, RR, Haffner, SM, Dagenais, G, Probstfield, J, Anderson, C, Diaz, R, Dans, A, Levine, M, Unger, T, Fagard, R, Diener, H-C, Sacco, RL, Zanchetti, A, Cohn, JN, Weber, M, Collaboration, ARBT

Publikováno v: JOURNAL OF HYPERTENSION. 29(4)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1064::86246618eff79a87a6ec65238b862def
http://ora.ox.ac.uk/objects/uuid:fe52d486-6a88-4422-a2ba-cdb88e59b130

Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy

Autor: Atkins, Rc, Briganti, Em, Lewis, Jb, Hunsicker, Lg, Braden, G, Champion, De, Crespigny, Pj, Deferrari, Giacomo, Drury, P, Locatelli, F, Wiegmann, Tb, Lewis, E. J.

Little is known of the effects of blood pressure reduction by specific classes of antihypertensive drugs on the association between proteinuria reduction and progression of kidney insufficiency and development of end-stage kidney disease in patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::361e2b5aa39bd02b319a12d38c86ef0c
http://hdl.handle.net/11567/206846

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.